Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CaM Kinase II alpha, p Thr286 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 6 publications
Supplier: Novus Biologicals NB3001840.02ML
Description
CaM Kinase II alpha Polyclonal specifically detects CaM Kinase II alpha in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
CaM Kinase II alpha (p Thr286) | |
Polyclonal | |
Western Blot 1:1000, Immunohistochemistry-Paraffin | |
P11275 | |
CAMK2A | |
Synthetic phospho-peptide corresponding to amino acid residues surrounding Thr286 conjugated to KLH | |
Affinity Purified | |
RUO | |
Primary | |
Specific for the ∼50k alpha-CaM Kinase II and the ∼60k beta-CaM Kinase II proteins phosphorylated at Thr286. Immunolabeling is blocked by the gamma-phosphatase treatment | |
Store at -20C. Avoid freeze-thaw cycles. |
Western Blot, Immunohistochemistry (Paraffin) | |
Unconjugated | |
10mM HEPES (pH 7.5), 0.15M NaCl, 0.1 mg/ml BSA and 50% Glycerol with No Preservative | |
calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha, calcium/calmodulin-dependent protein kinase II alpha, calcium/calmodulin-dependent protein kinase II alpha-B subunit, CaM kinase II alpha subunit, CaM kinase II subunit alpha, CAMKAcalcium/calmodulin-dependent protein kinase type II subunit alpha, CaMK-II alpha subunit, CaMK-II subunit alpha, CaMKIINalpha, CaM-kinase II alpha chain, EC 2.7.11, EC 2.7.11.17, KIAA0968calcium/calmodulin-dependent protein kinase type II alpha chain | |
Rabbit | |
50 kDa | |
0.02 mL | |
Neuroscience, Neurotransmission, Phospho Specific, Protein Kinase, Signal Transduction, Wnt Signaling Pathway | |
815 | |
Human, Mouse, Rat | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction